Trials / Completed
CompletedNCT00610155
A Methodology Study Of Brain Imaging Of Pain-Killers In Post-Traumatic Neuropathic Pain Patients
A Methodology Study To Assess The Feasibility Of Using Functional Magnetic Resonance Imaging (fRMI) To Quantify The Effects Of Analgesic Drugs In Post-Traumatic Neuropathic Pain Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is a methodology study designed to discover whether a brain imaging technology is a better way of compare the relative sensitivities of fMRI and subjective psychometric assessments of pain to multiple doses of pregabalin and tramadol SR in a cross-over clinical study design.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | BID |
| DRUG | Pregabalin | Dose 75 mg titrated to 150 mg, bid |
| DRUG | Tramadol SR | Dose 50mg titrated to 200 mg, bid |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2008-02-07
- Last updated
- 2021-01-22
- Results posted
- 2013-11-28
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00610155. Inclusion in this directory is not an endorsement.